Selective screening for atrial fibrillation using multivariable risk models
| Autor: | Ali H. Mokdad, Tasha B. Murphy, David T. Linker |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Male
medicine.medical_specialty Paroxysmal atrial fibrillation 030204 cardiovascular system & hematology Asymptomatic Risk Assessment Coronary artery disease 03 medical and health sciences Risk model 0302 clinical medicine Risk Factors Internal medicine Atrial Fibrillation medicine Humans Mass Screening 030212 general & internal medicine Stroke business.industry Incidence Age Factors Anticoagulants Atrial fibrillation Middle Aged medicine.disease United States Atherosclerosis Risk in Communities Heart failure Cardiology Female medicine.symptom Cardiology and Cardiovascular Medicine business |
| Zdroj: | Heart (British Cardiac Society). 104(18) |
| ISSN: | 1468-201X |
| Popis: | ObjectiveAtrial fibrillation can lead to stroke if untreated, and identifying those at higher risk is necessary for cost-effective screening for asymptomatic, paroxysmal atrial fibrillation. Age has been proposed to identify those at risk, but risk models may provide better discrimination. This study compares atrial fibrillation risk models with age for screening for atrial fibrillation.MethodsNine atrial fibrillation risk models were compared using the Atherosclerosis Risk in Communities study (11 373 subjects, 60.0±5.7 years old). A new risk model (Screening for Asymptomatic Atrial Fibrillation Events—SAAFE) was created using data collected in the Monitoring Disparities in Chronic Conditions study (3790 subjects, 58.9±15.3 years old). The primary measure was the fraction of incident atrial fibrillation subjects who should receive treatment due to a high CHA2DS2-VASc score identified when screening a fixed number equivalent to the age criterion. Secondary measures were the C statistic and net benefit.ResultsFive risk models were significantly better than age. Age identified 71 (61%) of the subjects at risk for stroke who subsequently developed atrial fibrillation, while the best risk model identified 96 (82%). The newly developed SAAFE model identified 95 (81%), primarily based on age, congestive heart failure and coronary artery disease.ConclusionsUse of a risk model increases identification of subjects at risk for atrial fibrillation. One of the best performing models (SAAFE) does not require an ECG for its application, so that it could be used instead of age as a screening criterion without adding to the cost. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|